Finance

Beta
Lists
KRK:WSE
Krka dd Novo Mesto
PLN 1,090.00
0.00%
(0.00) 1D
Jun 5, 5:00:00 PM GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for KRK...
Open
PLN 1,140.00
High
PLN 1,140.00
Low
PLN 1,088.00
Mkt. cap
8.43B
Avg. vol.
69.00
Volume
23.00
52-wk high
PLN 1,180.00
52-wk low
PLN 748.00
Shares outstanding
32.79M
No. of employees
13K
Open
PLN 1,140.00
High
PLN 1,140.00
Low
PLN 1,088.00
Mkt. cap
8.43B
Avg. vol.
69.00
Volume
23.00
52-wk high
PLN 1,180.00
52-wk low
PLN 748.00
Shares outstanding
32.79M
No. of employees
13K
News stories
From sources across the web
Profile
Krka, d. d., Novo mesto is an international generic pharmaceutical company with headquarters in Novo Mesto, Slovenia. In 2023, Krka Group's total sales amounted to 1.806 billion euros. The net profit of the Krka Group totalled €313.7 million. Krka sells products to more than 70 countries. In Slovenia the company has production sites in Ločna and Bršljin, Krško, Šentjernej and Ljutomer; several departments are spread across various parts of Ljubljana as well. Krka also has production and distribution centers in Russia, Poland, Croatia, and Germany. At the end of 2023, Krka Group had 12,753 employees. Wikipedia
About Krka dd Novo Mesto
CEOJože Colarič
Employees13.2K
FoundedApr 23, 1954
Headquarters-
SectorPharmaceutical industry
Websitekrka.biz
Last report
May 14, 2026
Fiscal period
Q1 2026
EPS / Est. (EUR)
- / -
Revenue / Est. (EUR)
565.77M / 541.60M
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
526.43M
485.49M
507.00M
565.77M
Cost of goods sold
223.46M
208.02M
208.84M
223.77M
Cost of revenue
223.46M
208.02M
208.84M
223.77M
Research and development expenses
45.34M
48.88M
44.42M
51.37M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
126.04M
119.68M
158.52M
140.38M
Operating expense
168.68M
167.29M
202.22M
190.40M
Total operating expenses
392.14M
375.31M
411.06M
414.17M
Operating income
134.29M
110.18M
95.94M
151.60M
Other non operating income
-65.44M
-2.55M
-3.17M
5.51M
EBT including unusual items
119.90M
96.04M
100.49M
148.27M
EBT excluding unusual items
119.90M
96.04M
98.43M
148.27M
Income tax expense
25.70M
19.06M
20.47M
27.32M
Effective tax rate
21.44%
19.85%
20.37%
18.43%
Other operating expenses
-2.70M
-1.26M
-721.00K
-1.35M
Net income
93.66M
77.08M
80.31M
120.95M
Net profit margin
17.79%
15.88%
15.84%
21.38%
Earnings per share
-
-
-
-
Interest and investment income
3.07M
2.69M
2.85M
-
Interest expense
-131.00K
-193.00K
-6.53M
-8.84M
Net interest expenses
2.94M
2.49M
-3.68M
-8.84M
Depreciation and amortization charges
-
-
-
-
EBITDA
156.37M
132.28M
118.66M
175.65M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more